• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IA型(酪氨酸酶阴性)眼皮肤白化病的分子基础。

Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.

作者信息

King R A, Oetting W S

机构信息

Department of Medicine, University of Minnesota, Minneapolis 55455.

出版信息

Pigment Cell Res. 1992;Suppl 2:249-53. doi: 10.1111/j.1600-0749.1990.tb00380.x.

DOI:10.1111/j.1600-0749.1990.tb00380.x
PMID:1409426
Abstract

Type IA (Tyrosinase negative) oculocutaneous albinism (OCA) is produced by mutations of the tyrosinase gene. We have found a total of 13 different mutations associated with type IA OCA. Analysis of the distribution of the 9 missense mutations shows that most of these mutations cluster in three areas of the gene. All but one of these mutations involve amino acids that are conserved between the mouse and human. Two clusters involve the copper A and copper B binding sites, and could disrupt the metal ion-protein interaction necessary for enzyme function. The third cluster is in exon I and could represent an important functional domain of the enzyme such as the tyrosine binding site. The deletion or insertion frameshift mutations are distributed throughout the coding region and do not appear to cluster. We conclude that a diverse number of mutations are responsible for type IA OCA and many individuals are compound heterozygotes for mutations responsible for this genetic disease (Table 3).

摘要

IA型(酪氨酸酶阴性)眼皮肤白化病(OCA)由酪氨酸酶基因突变引起。我们共发现了13种与IA型OCA相关的不同突变。对9种错义突变的分布分析表明,这些突变大多集中在基因的三个区域。除其中一个突变外,所有这些突变都涉及小鼠和人类之间保守的氨基酸。两个簇涉及铜A和铜B结合位点,可能会破坏酶功能所需的金属离子 - 蛋白质相互作用。第三个簇在外显子I中,可能代表酶的一个重要功能域,如酪氨酸结合位点。缺失或插入移码突变分布在整个编码区域,似乎没有聚集现象。我们得出结论,多种突变导致IA型OCA,许多个体是这种遗传病相关突变的复合杂合子(表3)。

相似文献

1
Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.IA型(酪氨酸酶阴性)眼皮肤白化病的分子基础。
Pigment Cell Res. 1992;Suppl 2:249-53. doi: 10.1111/j.1600-0749.1990.tb00380.x.
2
Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.I-A型(酪氨酸酶阴性)眼皮肤白化病的分子分析
Hum Genet. 1992 Nov;90(3):258-62. doi: 10.1007/BF00220074.
3
Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.I型(酪氨酸酶相关)眼皮肤白化病患者中,人类酪氨酸酶基因错义突变的非随机分布。
Mol Biol Med. 1991 Feb;8(1):19-29.
4
Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.IA型眼皮肤白化病中酪氨酸酶基因的三种不同移码突变。
Am J Hum Genet. 1991 Jul;49(1):199-206.
5
Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.与I型(酪氨酸酶相关)眼皮肤白化病相关的铜B结合区域突变分析。
Pigment Cell Res. 1992 Nov;5(5 Pt 2):274-8. doi: 10.1111/j.1600-0749.1992.tb00549.x.
6
Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.酪氨酸酶阴性眼皮肤白化病的分子基础:酪氨酸酶基因中的单个碱基插入或错义点突变。
Pigment Cell Res. 1992;Suppl 2:96-100. doi: 10.1111/j.1600-0749.1990.tb00356.x.
7
Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.一个患有IA型(酪氨酸酶阴性)眼皮肤白化病的大家庭的分子分析。
J Invest Dermatol. 1991 Jul;97(1):15-9. doi: 10.1111/1523-1747.ep12477808.
8
Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.I型(酪氨酸酶缺乏型)眼皮肤白化病中的酪氨酸酶基因突变定义了两个错义替换簇。
Am J Med Genet. 1992 Jul 15;43(5):865-71. doi: 10.1002/ajmg.1320430523.
9
Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.酪氨酸酶缺乏型眼皮肤白化病韩国患者中酪氨酸酶基因的常见和新突变
Mol Cells. 1997 Apr 30;7(2):187-91.
10
A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).一种导致1型眼皮肤白化病(OCA1)的酪氨酸酶基因新突变。
J Dermatol Sci. 2002 Feb;28(2):102-5. doi: 10.1016/s0923-1811(01)00141-4.